MAXHEALTH

Financial Performance & Corporate Actions

Q1 FY26 Results: The company reported strong performance for the quarter ended June 30, 2025. Consolidated revenue was ₹2,574 crore, marking a 27% year-on-year (YoY) growth. Profit After Tax (PAT) increased by 17% YoY to ₹345 crore. Network Operating EBITDA grew by 23% YoY to ₹613 crore. SEBI Index Inclusion: Max Healthcare Institute is set to be included in the Nifty 50 index as part of a semi-annual reshuffle by NSE Indices, with the changes effective September 30, 2025. This is a significant development as it will likely increase the stock's visibility and institutional investment. Expansion Initiatives: Max Healthcare is actively pursuing an aggressive expansion strategy. The company plans to invest ₹6,000 crore by 2028 to add 3,700 beds across India, with a focus on key locations in Delhi-NCR, Punjab, Mumbai, and Uttarakhand. It recently announced a new agreement to lease a 130-bed hospital in Dehradun, Uttarakhand, and has already opened a new 300-bed hospital in Dwarka, Delhi. 2. Operational Highlights: Occupancy & ARPOB: Occupancy for the quarter was at 76%, with a 26% YoY growth in Occupied Bed Days (OBDs). Average Revenue Per Occupied Bed (ARPOB) for Q1 FY26 was ₹78,000. EBITDA: The company has been successful in achieving EBITDA breakeven at its new greenfield hospital in Dwarka within a record time of six months. It has also shown significant YoY EBITDA growth in its recently acquired hospitals. Corporate Social Responsibility (CSR): The company provided free treatment to a significant number of patients from economically weaker sections in both outpatient (OPD) and inpatient (IPD) settings.